LPL Financial’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $122M | Sell |
724,989
-267,810
| -27% | -$45.8M | 0.03% | 502 |
|
|
2025
Q4 | $168M | Buy |
992,799
+589,033
| +146% | +$95.7M | 0.05% | 370 |
|
|
2025
Q3 | $58.3M | Buy |
403,766
+27,033
| +7% | +$3.69M | 0.02% | 776 |
|
|
2025
Q2 | $47.7M | Sell |
376,733
-27,130
| -7% | -$3.33M | 0.02% | 780 |
|
|
2025
Q1 | $51.7M | Sell |
403,863
-15,734
| -4% | -$2.13M | 0.02% | 673 |
|
|
2024
Q4 | $55.5M | Sell |
419,597
-192,858
| -31% | -$27.1M | 0.02% | 607 |
|
|
2024
Q3 | $89.2M | Sell |
612,455
-832
| -0.1% | -$120K | 0.04% | 411 |
|
|
2024
Q2 | $84.2M | Sell |
613,287
-6,277
| -1% | -$838K | 0.04% | 396 |
|
|
2024
Q1 | $85M | Buy |
619,564
+149,818
| +32% | +$20.5M | 0.05% | 371 |
|
|
2023
Q4 | $63.8M | Sell |
469,746
-56,965
| -11% | -$6.95M | 0.04% | 422 |
|
|
2023
Q3 | $64.4M | Sell |
526,711
-14,442
| -3% | -$1.84M | 0.05% | 374 |
|
|
2023
Q2 | $68.7M | Sell |
541,153
-86,172
| -14% | -$11.2M | 0.05% | 337 |
|
|
2023
Q1 | $81M | Sell |
627,325
-4,905
| -0.8% | -$642K | 0.06% | 281 |
|
|
2022
Q4 | $83M | Buy |
632,230
+88,697
| +16% | +$11.5M | 0.07% | 260 |
|
|
2022
Q3 | $63.6M | Buy |
543,533
+39,912
| +8% | +$4.96M | 0.06% | 289 |
|
|
2022
Q2 | $59.2M | Sell |
503,621
-7,484
| -1% | -$888K | 0.06% | 311 |
|
|
2022
Q1 | $66.6M | Sell |
511,105
-29,567
| -5% | -$3.85M | 0.06% | 299 |
|
|
2021
Q4 | $82.5M | Buy |
540,672
+2,990
| +0.6% | +$463K | 0.07% | 265 |
|
|
2021
Q3 | $86.9M | Buy |
537,682
+18,684
| +4% | +$3.14M | 0.08% | 234 |
|
|
2021
Q2 | $84.9M | Sell |
518,998
-23,607
| -4% | -$3.64M | 0.09% | 219 |
|
|
2021
Q1 | $81.7M | Buy |
542,605
+3,418
| +0.6% | +$543K | 0.09% | 205 |
|
|
2020
Q4 | $81.7M | Buy |
539,187
+21,965
| +4% | +$3.14M | 0.11% | 188 |
|
|
2020
Q3 | $70M | Buy |
517,222
+16,407
| +3% | +$2.23M | 0.11% | 177 |
|
|
2020
Q2 | $68.5M | Buy |
500,815
+132,363
| +36% | +$16.9M | 0.12% | 159 |
|
|
2020
Q1 | $39.7M | Sell |
368,452
-7,108
| -2% | -$818K | 0.09% | 206 |
|
|
2019
Q4 | $45.3M | Buy |
375,560
+3,566
| +1% | +$398K | 0.08% | 209 |
|
|
2019
Q3 | $37M | Sell |
371,994
-15,678
| -4% | -$1.64M | 0.08% | 226 |
|
|
2019
Q2 | $42.3M | Sell |
387,672
-47,162
| -11% | -$5.02M | 0.09% | 199 |
|
|
2019
Q1 | $48.6M | Sell |
434,834
-31,356
| -7% | -$3.44M | 0.11% | 172 |
|
|
2018
Q4 | $45M | Sell |
466,190
-20,621
| -4% | -$2.19M | 0.12% | 153 |
|
|
2018
Q3 | $59.4M | Buy |
486,811
+408
| +0.1% | +$48K | 0.14% | 128 |
|
|
2018
Q2 | $53.4M | Sell |
486,403
-25,822
| -5% | -$2.76M | 0.14% | 134 |
|
|
2018
Q1 | $54.7M | Buy |
512,225
+54,371
| +12% | +$6.03M | 0.15% | 128 |
|
|
2017
Q4 | $49.2M | Buy |
457,854
+14,355
| +3% | +$1.53M | 0.15% | 127 |
|
|
2017
Q3 | $49.3M | Buy |
443,499
+9,318
| +2% | +$996K | 0.17% | 110 |
|
|
2017
Q2 | $44.9M | Buy |
434,181
+406,071
| +1,445% | +$40M | 0.17% | 116 |
|
|
2017
Q1 | $2.73M | Buy |
28,110
+5,304
| +23% | +$508K | 0.02% | 677 |
|
|
2016
Q4 | $2.05M | Buy |
22,806
+2,274
| +11% | +$207K | 0.02% | 784 |
|
|
2016
Q3 | $1.97M | Buy |
20,532
+4,386
| +27% | +$417K | 0.02% | 780 |
|
|
2016
Q2 | $1.43M | Sell |
16,146
-799,989
| -98% | -$71.8M | 0.01% | 943 |
|
|
2016
Q1 | $73.4M | Sell |
816,135
-348,075
| -30% | -$31.1M | 0.2% | 105 |
|
|
2015
Q4 | $127M | Buy |
1,164,210
+589,056
| +102% | +$63.9M | 0.35% | 57 |
|
|
2015
Q3 | $60M | Sell |
575,154
-62,340
| -10% | -$7.48M | 0.33% | 64 |
|
|
2015
Q2 | $79.1M | Buy |
637,494
+56,640
| +10% | +$6.78M | 0.4% | 46 |
|
|
2015
Q1 | $65.8M | Buy |
580,854
+146,499
| +34% | +$16.2M | 0.34% | 62 |
|
|
2014
Q4 | $43.9M | Buy |
434,355
+12,051
| +3% | +$1.17M | 0.24% | 79 |
|
|
2014
Q3 | $37.9M | Sell |
422,304
-59,937
| -12% | -$5.26M | 0.23% | 88 |
|
|
2014
Q2 | $41.3M | Buy |
482,241
+49,731
| +11% | +$3.92M | 0.24% | 80 |
|
|
2014
Q1 | $34.1M | Buy |
432,510
+139,575
| +48% | +$11.6M | 0.21% | 99 |
|
|
2013
Q4 | $22.2M | Sell |
292,935
-51,705
| -15% | -$3.67M | 0.14% | 148 |
|
|
2013
Q3 | $23.2M | Buy |
344,640
+149,448
| +77% | +$9.79M | 0.15% | 135 |
|
|
2013
Q2 | $11.3M | Buy |
+195,192
| New | +$11.3M | 0.08% | 219 |
|
Other funds holding IBB
CB
LPL Financial's IBB Position: Q1 2026 in Review
LPL Financial reduced its iShares Biotechnology ETF (IBB) stake by 27% in Q1 2026, selling an estimated $45.8M and leaving 724,989 shares worth $122M. The position accounts for 0.03% of the portfolio, ranked #502.
LPL Financial first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $168M in Q4 2025. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- LPL Financial held 724,989 shares of iShares Biotechnology ETF worth $122M as of Q1 2026.
- LPL Financial sold 267,810 iShares Biotechnology ETF shares in Q1 2026, an estimated $45.8M.
- iShares Biotechnology ETF made up 0.03% of LPL Financial's portfolio in Q1 2026, its #502 holding.
- LPL Financial first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
- LPL Financial's iShares Biotechnology ETF position peaked at $168M in Q4 2025.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.